{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreickdljkek5452ohe2chd3y3rpxfwsx333a2rkkdty3qf7txnbxktu",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mlcpaj4px6s2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicmawq36y3ig444mob5um5c7nouqhtxvrptfqi4nmb4rbzmoknv64"
    },
    "mimeType": "image/jpeg",
    "size": 70296
  },
  "path": "/2026/05/07/fda-political-interference-sanofi-tzield-rfk-hhs-ssri/?utm_campaign=rss",
  "publishedAt": "2026-05-07T14:54:12.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "D.C. Diagnosis",
    "Pharma",
    "Politics",
    "chronic disease",
    "Congress",
    "drug development",
    "FDA",
    "Mental Health",
    "Pharmaceuticals",
    "Policy",
    "public health",
    "STAT+"
  ],
  "textContent": "A political appointee gets in the way of a Sanofi drug's approval, and more from STAT's D.C. Diagnosis newsletter.",
  "title": "STAT+: More political interference at the FDA?",
  "updatedAt": "2026-05-07T14:54:17.000Z"
}